Literature DB >> 2473624

Serum levels of neutrophil and eosinophil chemotactic activities in mastocytosis.

G Granerus1, L Håkansson, G Roupe, P Venge.   

Abstract

Neutrophil and eosinophil chemotactic activities (NCA and ECA) were measured in serum from twenty-two patients with urticaria pigmentosa or systemic mastocytosis. NCA was also measured after heating serum to 56 degrees C (heat-stable NCA). Although these factors were increased in about half of the patients there was no correlation with histamine release as estimated by the excretion of the main histamine metabolite methylimidazoleacetic acid (MelmAA) in urine. A significant increase in heat-stable NCA, however, was found in patients with pruritus and abnormal high values of MelmAA. It is concluded that only heat-stable NCA is a specific mast cell mediator, but that the heat-labile NCA and ECA are dependent on mast cells for their production by a different cell, tentatively identified as the macrophage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473624     DOI: 10.1007/bf02222241

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  6 in total

1.  New method for the measurement of eosinophil migration.

Authors:  L Håkansson; D Westerlund; P Venge
Journal:  J Leukoc Biol       Date:  1987-12       Impact factor: 4.962

2.  Urinary excretion of histamine, methylhistamine and methylimidazoleacetic acids in man under standardized dietary conditions.

Authors:  G Granerus
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites.

Authors:  J J Keyzer; J G de Monchy; J J van Doormaal; P C van Voorst Vader
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

4.  Studies on histamine metabolism in mastocytosis.

Authors:  G Granerus; J H Olafsson; G Roupe
Journal:  J Invest Dermatol       Date:  1983-05       Impact factor: 8.551

5.  Heat-labile neutrophil chemotactic activity in subjects with asthma after allergen inhalation: relation to the late asthmatic reaction and effects of asthma medication.

Authors:  P Venge; R Dahl; L Håkansson
Journal:  J Allergy Clin Immunol       Date:  1987-11       Impact factor: 10.793

6.  Treatment of two mastocytosis patients with a histidine decarboxylase inhibitor.

Authors:  G Granerus; J H Olafsson; G Roupe
Journal:  Agents Actions       Date:  1985-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.